Avoro Capital Advisors LLC Q2 2023 Filing
Filed August 14, 2023
Portfolio Value
$7371.2T
Holdings
43
Report Date
Q2 2023
Filing Type
13F-HR
All Holdings (43 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | APLSAPELLIS PHARMACEUTICALS INC | 11,111,111 | $1012.2T | 13.73% | |
| 2 | HZNPHORIZON THERAPEUTICS PLC | 7,000,000 | $720.0T | 9.77% | |
| 3 | UTHUNITED THERAPEUTICS CORP | 2,909,999 | $642.4T | 8.71% | |
| 4 | SRPTSAREPTA THERAPEUTICS INC | 4,627,888 | $530.0T | 7.19% | |
| 5 | ARGXARGENX SE | 1,263,500 | $492.4T | 6.68% | |
| 6 | MDGLMADRIGAL PHARMACEUTICALS INC | 1,515,151 | $350.0T | 4.75% | |
| 7 | BMRNBIOMARIN PHARMACEUTICAL INC | 4,000,000 | $346.7T | 4.70% | |
| 8 | AM6AMICUS THERAPEUTICS INC | 27,400,000 | $344.1T | 4.67% | |
| 9 | SGENUSDSEAGEN INC | 1,759,606 | $338.7T | 4.59% | |
| 10 | ASNDASCENDIS PHARMA | 3,580,555 | $319.6T | 4.34% | |
| 11 | OPHTEURIVERIC BIO INC | 8,050,000 | $316.7T | 4.30% | |
| 12 | KRYSKRYSTAL BIOTECH INC | 2,560,811 | $300.6T | 4.08% | |
| 13 | ALNYALNYLAM PHARMACEUTICALS INC | 1,105,000 | $209.9T | 2.85% | |
| 14 | MRTXEURMIRATI THERAPEUTICS INC | 5,555,555 | $200.7T | 2.72% | |
| 15 | XENEXENON PHARMACEUTICALS INC | 4,900,000 | $188.7T | 2.56% | |
| 16 | CBAYUSDCYMABAY THERAPEUTICS INC | 10,300,000 | $112.8T | 1.53% | |
| 17 | —DICE THERAPEUTICS INC | 2,199,342 | $102.2T | 1.39% | |
| 18 | KYMRKYMERA THERAPEUTICS INC | 3,855,000 | $88.6T | 1.20% | |
| 19 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 1,725,000 | $88.0T | 1.19% | |
| 20 | BCRXBIOCRYST PHARMACEUTICALS INC | 12,055,000 | $84.9T | 1.15% | |
| 21 | NUVLNUVALENT INC | 1,600,000 | $67.5T | 0.92% | |
| 22 | ROIVROIVANT SCIENCES LTD | 5,806,162 | $58.5T | 0.79% | |
| 23 | SNDXSYNDAX PHARMACEUTICALS INC | 2,650,000 | $55.5T | 0.75% | |
| 24 | IOVAIOVANCE BIOTHERAPEUTICS INC | 6,700,000 | $47.2T | 0.64% | |
| 25 | MNKDMANNKIND CORP | 9,100,000 | $37.0T | 0.50% | |
| 26 | RAREULTRAGENYX PHARMACEUTICAL INC | 750,000 | $34.6T | 0.47% | |
| 27 | MRNS*MARINUS PHARMACEUTICALS INC | 3,150,000 | $34.2T | 0.46% | |
| 28 | KURAKURA ONCOLOGY INC | 3,105,000 | $32.9T | 0.45% | |
| 29 | GLUEMONTE ROSA THERAPEUTICS INC | 4,535,000 | $31.1T | 0.42% | |
| 30 | RNAAVIDITY BIOSCIENCES INC | 2,510,000 | $27.8T | 0.38% | |
| 31 | DSGNDESIGN THERAPEUTICS INC | 3,500,000 | $22.1T | 0.30% | |
| 32 | —MERSANA THERAPEUTICS INC | 6,375,000 | $21.0T | 0.28% | |
| 33 | WHWKAADI BIOSCIENCES INC | 2,849,402 | $19.5T | 0.26% | |
| 34 | PMVPPMV PHARMACEUTICALS INC | 3,060,000 | $19.2T | 0.26% | |
| 35 | VRCAVERRICA PHARMACEUTICALS INC | 2,954,064 | $17.0T | 0.23% | |
| 36 | ARWRARROWHEAD PHARMACEUTICALS INC | 357,403 | $12.7T | 0.17% | |
| 37 | MCRB1EURSERES THERAPEUTICS INC | 2,500,000 | $12.0T | 0.16% | |
| 38 | —IKENA ONCOLOGY INC | 1,640,000 | $10.8T | 0.15% | |
| 39 | FRXFENNEC PHARMACEUTICALS INC | 1,200,000 | $10.6T | 0.14% | |
| 40 | TNGXTANGO THERAPEUTICS INC | 1,640,000 | $5.4T | 0.07% | |
| 41 | IOBTIO BIOTECH INC | 2,055,883 | $4.0T | 0.05% | |
| 42 | —TALARIS THERAPEUTICS INC | 500,000 | $1.5T | 0.02% | |
| 43 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 286,459 | $129.1B | 0.00% |